Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.Baituxiao Botanical Formula: Product, Label and Evidence Profile
Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…
Read more
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read moreNamed profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
Prednisone in Canine Cancer Care: A Timing and Safety Discussion
Prednisone is a prescription corticosteroid used in several veterinary cancer contexts, including components of lymphoma protocols and selected palliative plans. Its purpose, timing and taper must be defined…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Appetite Support: Find and Treat the Reason a Dog Is Not Eating
Reduced appetite can result from nausea, pain, fever, constipation, oral disease, swallowing difficulty, medication effects, tumor location, stress, or metabolic illness. Appetite support starts by investigating and treating…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read more
Palliative Care Plan: Concurrent Comfort From Diagnosis Onward
Palliative care focuses on comfort and function and can begin at diagnosis while tumor-directed treatment continues. Hospice is a later, more intensive form of comfort-focused care; neither means…
Read more
Veterinary Rehabilitation During and After Cancer Care
Veterinary rehabilitation uses a medically supervised assessment and individualized plan to address pain, weakness, mobility limits, deconditioning, and functional goals. In oncology it must be coordinated with the…
Read more
Palliative-Intent Radiation: Symptom Goal and Tradeoffs
Palliative radiation uses a comfort-focused treatment plan for selected painful or obstructive tumors and must be evaluated by symptom goal, burden, and field-specific risk.
Read moreTyrosine Kinase Inhibitors: A Class-Level Monitoring Framework
Tyrosine kinase inhibitors are not one interchangeable drug class; target profile, label, evidence, dosing, monitoring, and adverse effects differ by product and patient.
Read moreImatinib in Canine Mast Cell Tumor Care: Extra-Label Evidence Review
Imatinib has published canine mast cell tumor experience but is not interchangeable with veterinary-labeled TKIs and requires specialist, legal, formulation, and evidence review.
Read more